Mathematical modelling in ranking timolol single active ingredient drugs by the efficacy criterion
DOI:
https://doi.org/10.31288/oftalmolzh202048388Keywords:
a priori ranking, glaucoma, Timolol drugsAbstract
Background: Glaucoma is a disease that is associated with elevated intraocular pressure. Most commonly, single active agent beta-adrenoceptor blockers (particularly, timolol-only preparations) are used as a first-line therapy for primary open-angle glaucoma (POAG).
Purpose: To compare the efficacy of various timolol-only preparations available in the Ukrainian pharmaceutical market as a monotherapy for POAG on the basis of expert assessment.
Methods: Forty-four ophthalmologists from various Ukrainian regions participated in the questionnaire survey. The participants varied in length of service, academic degree and experience in managing the disease. Survey data were processed using the method of the prior ranking of factors.
Results: Mathematic modeling was used to construct the bar chart of ranks from the processed results of the survey. The overall impact of any factor on the examined variable was assessed through the sum of ranks.
Conclusion: The method of the prior ranking of factors was used to establish that, in the opinion of the surveyed ophthalmologists, CUSIMOLOL, ARUTIMOL and OFTAN TIMOLOL are the three most efficient timolol-only preparations for the treatment of POAG.
References
1.Kryvov’iaz OV. [Glaucoma patients’ quality of life: social and pharmacoeconomic aspects]. Dnipro: Litograf; 2017. Ukrainian.
2.European Glaucoma Society. Terminology and guidelines for glaucoma. 4th ed. Savona: PubliComm; 2014.
3.Groshovyi TA, Martseniuk VP, Kucherenko LІ, et al. [Mathematic planning of experiments in pharmaceutical research]. Ternopіl: Ukrmedkniga; 2008. Ukrainian.
4.Babintseva LIu. [Expert survey to assess the efficacy of medications]. Medychna informatika ta inzheneriia. 2014;1:21-3. Ukrainian.
5.The State Register of Medicinal Products of Ukraine. Available from: http://www.drlz.com.ua. Ukrainian.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 В. М. Сакович, О. В. Макаренко, О. В. Кривов'яз, Ю. О. Томашевська, В. М. Коваль
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
